Adam Milewski
President
AMCO International Manufacturing & Design, Inc.
410 Conselyea Street
Brooklyn , NY 11211-2202
United StatesFEI 3005906887Issued Jun 25, 2024Center for Devices and Radiological Health
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3005906887.
Violations1
Issue DateJun 25, 2024
Product TypeMedical Devices
StatusOpen
Letter Details
Firm
AMCO International Manufacturing & Design, Inc.
Location
Adam Milewski
President
AMCO International Manufacturing & Design, Inc.
410 Conselyea Street
Brooklyn , NY 11211-2202
United States
FEI Number
3005906887
Country
United States
Issue Date
June 25, 2024
Issuing Office
Center for Devices and Radiological Health
Product Type
Medical Devices
Status
Open
Summary
AMCO International Manufacturing & Design, Inc. manufactured replacement batteries for Automated External Defibrillators (AEDs) without obtaining required premarket approval, violating FDA regulations that mandate PMA submissions for AED accessories. During a March 2024 inspection, the FDA determined that the company's batteries—including models AM9146-2, AM5070, AM1000, 5L318, 6L785, 5L500, and AM9141—qualified as medical devices requiring premarket approval under a 2015 final order effective February 3, 2015. The company failed to submit required PMA applications for these necessary AED accessories, which are critical components for AED functionality in detecting heart rhythms and delivering electrical shocks.
AMCO International Manufacturing & Design, Inc. FDA Warning Letter, June 25, 2024